Standfirst:
Founded in Taiwan by Swedish entrepreneurs, SHL Medical has grown into a global leader in autoinjector technology. Now headquartered in Switzerland, the company continues to drive innovation and sustainability in injectable drug delivery, expanding its presence through strategic partnerships and cutting-edge solutions.
The entrepreneurial spirit that started the journey
In 1989, Swedish entrepreneur Roger Samuelsson, along with co-founder Martin Jelf, saw an untapped opportunity to revolutionize the medical technology sector by establishing a company in Taiwan. Initially focusing on healthcare products, Samuelsson had a bold vision for the future – one that would lead to the creation of SHL Medical. Over time, the company shifted its focus to developing innovative self-injection devices, transforming the way patients manage their treatments. Taiwan, an unconventional choice for medical device manufacturing at the time, became the foundation for Samuelsson’s venture.
For the next 30 years, Samuelsson remained in Taiwan, working closely with his team to build the business and a sustainable manufacturing model. His persistence, coupled with strong teamwork, helped SHL Medical become a pioneering force in autoinjector technology. Together, they built a diverse, open, and innovative work environment that became the backbone of SHL Medical’s core value of delivering together. Samuelsson’s Swedish roots shaped a leadership style focusing on quality and sustainability – values that have remained at the core of SHL Medical’s operations today.
A global leader in self-injection solutions
Over the decades, SHL Medical has evolved far beyond its humble beginnings in Taiwan. Working with leading pharmaceutical and biotech companies, the company provides end-to-end solutions to develop advanced injectable solutions. To date, over 50 combination products featuring SHL Medical’s autoinjectors have been successfully launched, addressing chronic conditions such as type 2 diabetes, cardiovascular diseases, obesity, and more – solidifying the company’s reputation for reliability and innovation.
A key factor in SHL Medical’s success is its vertically integrated business model. By keeping most processes in-house – from design to final assembly – the company ensures stringent quality control, high levels of flexibility, and rapid response to market demands. Strategic acquisitions and partnerships have further fueled its global growth, accelerating its entry into new markets and enhancing its production capabilities. With key facilities in Switzerland, Sweden, Taiwan, and the USA, SHL Medical continues to scale its global presence. The introduction of new sites in North Charleston, USA, Zug, Switzerland, and Taoyuan-Nanmei, Taiwan demonstrates the company’s commitment to expanding its production capacity to serve its global client base.
Leading by example
Looking ahead, the company remains deeply committed to Taiwan as a critical hub for its global operations while expanding into new therapeutic areas and bolstering its sustainability efforts. The signing of a Letter of Intent (LOI) with Taiwan’s Ministry of Economic Affairs (MOEA) reinforces its long-term vision of fostering greater collaboration with local industries.
In addition, the company is forging ahead with acquisitions and partnerships to increase its global footprint and enhance its capabilities. Its Alliance Program plays a key role in this expansion, allowing SHL Medical to collaborate with other innovators and explore new markets.
Sustainability is also at the forefront of SHL Medical’s future. Recognizing the importance of reducing its environmental impact, the company has ramped up its sustainability initiatives. One of the major milestones was the introduction of its first electric truck in Taiwan to reduce carbon emissions in its logistics operations. The company has already achieved 74% of its waste reduction target, with a continued push toward optimization of its processes and increased use of renewable energy across its facilities. SHL Medical was awarded the EcoVadis Silver medal in 2023 for its sustainability efforts.
Swedish roots, global impact
Roger Samuelsson’s vision, which began in Taiwan, has made SHL Medical a global leader in self-injection solutions. As the company continues to grow, its commitment to enabling patients’ independence ensures it remains at the forefront of innovation and corporate responsibility.
The Swedish Chamber of Commerce Taipei is proud to highlight the incredible achievements that SHL Medical has achieved as a global force in the medical technology field. The company’s journey is a testament to innovation, resilience, and the impact that visionary leadership can have on industries and communities alike.
—— 中文版—–
內容提要：
SHL Medical (瑞健醫療) 是瑞典企業家於台灣創立的企業，隨著公司規模成長，現已成為自動注射器技術的全球領導品牌。目前公司總部設於瑞士，持續推動注射藥物輸送領域的創新與永續發展，透過策略合作關係及先進的解決方案拓展業務版圖。
開創新局的創業家精神
1989 年，瑞典企業家孫羅傑 (Roger Samuelsson) 與創業夥伴 Martin Jelf 發現一個能夠在醫療科技領域引領革新，卻尚待開發的大好機會，因此決定在台灣創業。起初，孫羅傑專注生產醫療保健產品，同時也對未來懷抱著遠大的願景。這樣的願景造就了日後 SHL Medical 的創立。公司後來逐漸將營運焦點集中於創新自動注射器的開發，並致力於患者自主管理治療方式的轉型。在當時，選擇台灣作為高精密醫療相關用品的製造基地並非主流的決策，但孫羅傑決意在此開創事業。
其後 30 年，孫羅傑都待在台灣，與團隊緊密合作，建立事業並創設永續的生產模式。孫羅傑堅持不懈的毅力以及強大的團隊合作，打造 SHL Medical 成為自動注射器技術的先驅。創辦人與團隊攜手打造了多元、開放及創新的工作環境，為 SHL Medical 的核心價值「共同達標」(delivering together) 提供強大後盾。孫羅傑來自瑞典的背景，造就其注重品質及永續發展的領導風格，而這些價值至今仍是 SHL Medical 的營運核心。
自動注射解決方案全球領導品牌
經過數十年，SHL Medical 逐漸成長，現已遠遠超越在台灣草創初期的規模。公司透過與頂尖製藥及生技公司合作，提供端對端解決方案，以開發先進的注射解決方案。截至目前，已經有超過 50 種配備 SHL Medical 自動注射器的複合式產品成功推出，可用於治療第二型糖尿病、心血管疾病、肥胖等慢性病症，確立了 SHL Medical 可靠及創新的聲譽。
SHL Medical 獲得成功的其中一項關鍵因素，是垂直整合的商業模式。從設計到總組裝，大多數製程均由公司內部負責，藉以確保嚴格的品質控管、高度的彈性，並能夠快速回應市場需求。策略併購與合作關係更進一步推動 SHL Medical 的全球成長，加速進入新市場並提升產能。SHL Medical 在瑞士、瑞典、台灣及美國設有主要廠房，並持續拓展全球業務版圖。公司致力於擴大產能，並在美國北查爾斯頓、瑞士楚格及台灣桃園南美等地創建新廠，服務來自全球的客群。
樹立典範
展望未來，SHL Medical 將持續深耕台灣，將其作為全球營運的關鍵樞紐，同步拓展全新治療領域，並持續強化永續發展工作。SHL Medical 與台灣經濟部 (MOEA) 簽訂之意向書 (LOI)，亦強化其長期願景，拓展與本地產業的合作關係。
此外，公司也透過併購及合作關係迅速成長，積極開發全球市場並提升產能。SHL Medical 的結盟計畫是擴展的關鍵，助其達成與其他創新企業的協同合作並探索新市場。
永續發展亦是 SHL Medical 未來的發展重點。由於深知減少環境衝擊的重要性，瑞健持續加強永續發展措施。其中一個重要的里程碑是將電動卡車引進台灣公司，以減少物流作業的碳排量。公司已達成 74% 的廢棄物減量目標，並持續推動流程最佳化，針對所有廠房提升可再生能源的使用率。SHL Medical 為永續發展貢獻的心力有目共睹，並獲頒 2023 年 EcoVadis 銀獎。
立足瑞典，影響國際
孫羅傑的願景從台灣開始，引領 SHL Medical 成為自動注射解決方案的全球領導品牌。公司持續成長的同時，也致力實現病患的自主照護，因此在創新和企業責任方面均維持領先群倫的地位。
台北瑞典商會很榮幸報告 SHL Medical 以國際領導品牌之姿，在醫療科技領域取得卓越的成果。SHL Medical 的營運證明了創新、韌性，以及充滿遠見的領導能力對於產業及社群之影響。
Picture sources: SHL Medical AG